CERCELL A/S: Financial statements 2012
CVR: 31940346
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
CERCELL A/S (CVR 31940346) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 295,737 and a net result of DKK 3,060. Equity in the 2012 report amounted to DKK 127,489. The solvency ratio was 93.4%.
- Gross Profit
- DKK 295,737
- Profit/Loss
- DKK 3,060
- Equity
- DKK 127,489
- Total Assets
- DKK 136,489
Official annual report
Keep an eye on CERCELL A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of September 11, 2012, Flemming Petersen has joined the board of directors of CERCELL A/S.
As of September 11, 2012, Per Stobbe has joined the board of directors of CERCELL A/S.
As of September 11, 2012, Peter Mosegaard has joined the board of directors of CERCELL A/S.
About CERCELL A/S
CERCELL A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2009. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named CERCELL ApS. The management consists of Kevin Robert Klejn and Flemming Petersen. The board consists of August Kisling Stobbe, Flemming Petersen and Per Stobbe. The company is owned by Stobbe GmbH. According to the 2025 annual report, the company had an average of 17 employees. In 2025, the company reported a gross profit of DKK 10,765,334 and a net result of DKK 1,016,303 compared with DKK 425,117 the year before. Equity in the 2025 report amounted to DKK 10,726,399.